🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Neal Dunlap

Neal Dunlap

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer”.

Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non–Small Cell Lung Cancer

Journal of Clinical Oncology(2024)10.1200/jco.24.00022

N/A

1.1DataRank · unranked

39 citations

Chen Hu, Daniel A. Pryma, Fenghai Duan, M.M. Matuszak, Ying Xiao +22 more

Avasopasem manganese (GC4419) protects against cisplatin-induced chronic kidney disease: An exploratory analysis of renal metrics from a randomized phase 2b clinical trial in head and neck cancer patients

Redox Biology(2023)10.1016/j.redox.2022.102599

N/A

0DataRank · unranked

17 citations

G Vasquez Martinez, Casey Pulliam, Michael S. Petronek, Emily J. Steinbach, Varun Monga +20 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more

NRG Oncology HN006: Randomized phase II/III trial of sentinel lymph node biopsy versus elective neck dissection for early-stage oral cavity cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.tps6093

N/A

0DataRank · unranked

11 citations

Pedro A. Torres‐Saavedra, Neal Dunlap, Beth M. Beadle, Steven S. Chang, Rathan M. Subramaniam +13 more

Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: an individual patient data meta-analysis

The Lancet Oncology(2024)10.1016/s1470-2045(24)00016-0

N/A

0DataRank · unranked

9 citations

Emily Morris, Krithika Suresh, Phuc Félix Nguyen‐Tan, David I. Rosenthal, Maura L. Gillison +18 more

1326MO RTOG 1016 long-term update and smoking analysis

Annals of Oncology(2025)10.1016/j.annonc.2025.08.1958

N/A

0DataRank · unranked

0 citations

Kristin Atwood, Jimmy J. Caudell, Paul M. Harari, Erich M. Sturgis, David J. Adelstein +14 more

Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma

(2023)10.1158/1078-0432.c.6532305.v1

N/A

0DataRank · unranked

0 citations

Shuchi Gulati, Sarah Palackdharry, Benjamin H. Hinrichs, Francis P. Worden, Matthew Old +21 more